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INTRODUCTION 
The choice of a blood-culture system to be used in a 
medical institution depends mainly on the financial 
resources. The most economic but not necessarily opti- 
mal system would probably be the in-house production 
of adequately supplemented aerobic and anaerobic 
broth media. Laboratories processing only limited 
numbers of blood cultures may choose one of the 
manual blood-culture systems, but automated systems 
like one of the continuous-monitoring blood-culture 
systems described below should be favored. This review 
is introduced with general considerations on blood- 
culture evaluations before the description of the most 
commonly known and used blood-culture systems 
followed by an overview of the results obtained with 
these. A blood-culture system can be selected based 
on scientific reports as a supplement to commercial 
arguments. 
GENERAL CONSIDERATIONS ON BLOOD-CULTURE 
SYSTEM EVALUATIONS 
One of the most challenging tasks facing clinical micro- 
biologists is the vahdation of new blood-culture systems 
[l]. For the ideal clinical comparative evaluation, draw- 
ing of additional blood from each patient for parallel 
testing is not always possible. In addition, about 90% of 
blood cultures are normally negative, and therefore of 
no value for a comparison. Moreover, up to 3% of the 
microorganisms isolated are considered to be contami- 
nants (Figures 1 and 2). A wide range of more than 20 
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different microbial species considered to be clinically 
relevant, including yeasts, anaerobes, and fastidious 
organisms, should be isolated during an evaluation. To 
test the ability of automated systems in detecting posi- 
tive cultures, at least 500 cultures determined to be 
negative by the instrument should be blindly sub- 
cultured at the end of the incubation period. Instru- 
ment performance may be considered acceptable when 
>98% of all blood-culture vials positive on subcultures 
are detected by the instrument [l]. A French working 
group recommended the evaluation of about 1000 
blood-culture sets with systematic subcultures of all 
vials to be included in any study. The subculture result 
is proposed to be the microbiological reference, so that 
sensitivity, specificity and positive and negative predic- 
tive values can be calculated for a new automated 
blood-culture system [2], 
For the approval of blood-culture systems, the FDA 
guidelines require a comparison of recovery of at least 
600 clinically important isolates from over 370 different 
septic episodes [3]. Since the positivity rate is directly 
related to the volume of blood cultured [4-91 (Figures 
1 and 2 ) ,  the volume of blood inoculated into each vial 
must be controlled so that inadequately filled bottles 
can be excluded from the evaluations. Therefore, at  
least 8000 blood-culture sets should be evaluated, 
assuming positivity rates of 6-16%, an acceptable 
contamination rate of up to 4% (Tables 1-3), and about 
80% compliant sets, depending on the institutions [3]. 
Since no blood-culture system may be considered as an 
absolute reference, sensitivities and specificities cannot 
be accurately calculated [3,10]. A new blood-culture 
system should be compared to a system already approved 
by the FDA. The new system may be considered 
validated if it detected >95% of the microorganisms 
detected by the reference system [1]. However, earlier 
studies of manual blood-culture systems evaluating less 
than 5000 blood-culture sets remain useful, even 
though statistical conclusions may not be as firm as 
for recent, well-controlled evaluations where >8000 
blood-culture sets were evaluated (Tables 1-3). 
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Figure 1 Yield of pathogens and contamination rate of 10 498 manual aerobic blood-culture vials (Septi-Chek BHI, Signal 
and Hkmoline) related to the volume of blood cultured. O n  average, 9k2.8 mL of blood was inoculated during the studies 
performed at the University Hospital Geneva [8,9]. 
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Figure 2 Yield of pathogens and contamination rate of BACTEC Plus aerobic/F vials related to the volume of blood 
cultured (average=7.322 mL), during the study performed at the University Hospital Geneva [18]. 
The volume of blood inoculated into each vial 
should be determined during all blood-culture evalu- 
ations, as previously mentioned. Weighing the vials 
before and after the blood inoculation is the most 
accurate procedure. It remains the only reliable method 
when small volumes of blood can be obtained, in 
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Figure 3 Cumulative positivity rate for three blood-culture sets in 448 septic episodes in patients not receiving antibiotics, 
and for 149 septic episodes in patients receiving antibiotics at the time of blood collection for culture at the University 
Hospital Geneva [22]. 
particular from pediatric patients [ l l ] ,  but this pro- 
cedure is time-consuming. For larger volumes (> 5 d) 
of blood cultured from adult patients, visual com- 
parisons of liquid levels to levels of non-inoculated vials 
may be sufficient. Only sets with adequately filled vials 
and with limited differences in volume should be 
included in the evaluations. The method used to deter- 
mine the blood volume inoculated as well as the 
inclusion criteria should be well indicated in reports 
and publications. 
It is recommended to determine every identified 
microorganism as either the cause of sepsis, as contami- 
nant, or indeterminate as the cause of sepsis, according 
to established and widely accepted criteria [12,13]. 
Once these categories have been attributed, the overall 
number of compliant blood-culture sets containing one 
or more microorganisms causing sepsis and the number 
of sets contaminated should be calculated. The result 
section or tables should contain the numbers of patho- 
gens isolated from both systems, or from either system 
only. Based on such results, most studies apply the 
McNemar exact test for statistical analysis [14]. It is 
usefd to know the same distribution for contaminants 
per system. Several recent studies [15-221 have analyzed 
the performance of different systems per septic episode, 
which provides more relevant information for indivi- 
dual patient care. In addition, many evaluations 
separately analyzed the results obtained from patients 
receiving antimicrobial therapy [I 1,15,16,18,20,22-301 
(Figure 3). 
Peer-reviewed publications are a considerable aid 
in choosing a new blood-culture system. Additional 
seeded blood-culture studies, which may be performed 
in almost all laboratories, are recommended as an 
important verification of a new blood-culture system 
111. 
The time needed for a system to reveal a positive 
blood culture is an important criterion. However, too 
many variables of different institutions (such as distance 
between wards and the laboratory, transport system 
available, patient population served) limit the value of 
comparisons of detection times determined at mfferent 
sites. In addition, investigators use different time inter- 
vals to calculate the detection times of blood-culture 
systems. For the studies conducted in Geneva, the 
detection time has always been considered as the time 
interval between the vial inoculation at the patient’s 
bedside and the detection of a positive blood culture by 
the technician after a positive Gram stain result during 
the working hours from 7a.m. to 7p.m. Another 
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Table 4 Media and vial characteristics for commercially available blood-culture systems accordmg to package inserts and 
references [6,71,77] 
~~ ~ 
Broth Inoculum Manipulation 
Basic volume volume Headspace % SPS Special before 
System Vial medmm (d) (mL) atmosphere concentratlon addmves incubation 
Himoline 
Septi-Chek 
Signal 
Isolator 
BACTEC 
BacT/Alert 
ESP 
Vital 
Aerobic 
TSB 
BHI 
Release 
Standard aerobic/F 
Standard anaerobic/F 
Plus aerobic/F 
Plus anaerobic/F 
Peds Plus /F 
Lytic anaerobic/F 
Myco/F Lytic 
Aerobic 
Anaerobic 
Pedi-BacT 
Aerobic FAN 
Anaerobic FAN 
ESP 80 A aerobic 
ESP 80 N anaerobic 
EZ DRAW 40 A 
EZ DRAW 40 N 
Aerobic 
Anaerobic 
TSB 
TSB 
BHI 
BHI 
TSB 
SCD 
SCD 
SCD 
SCD 
SCD 
SCD 
MB 7H9 
TSB 
TSB 
BHI 
BHI 
BHI 
SCP 
PP 
SCP 
PP 
SCD 
SCD 
40 
70 
70 
70 
70 
(0.7) 
25 
25 
25 
25 
40 
40 
40 
40 
40 
20 
40 
40 
80 
80 
40 
40 
40 
40 
<10 Air 
8-10 c02 
8-10 co2 
8-10 COS 
-10 CO2 
6-10 
5 COz in air 
5 COzwithNz 
8-10 COz in air 
<4 COzinair  
8-10 COZ with N2 
1-5 COz in air 
8-10 COz with Nz 
8-10 COz in air 
8-10 COz with Nz 
<4 COz in air 
8-10 COzinair  
8-10 COz with N2 
< lo  C02 in air 
<10 C O z i n N 2  
<5 COz inair 
<5  COz in N2 
10 COz in air 
10 COzwith Nz 
0.025 
0.05 
0.025 
0.025 
0.03 
0.025 
0.025 
0.05 
0.05 
0.02 
0.035 
0.025 
0.035 
0.035 
0.02 
0.05 
0.05 
0.006 
No 
0.006 
N o  
0.025 
0.165% saponin 
2.8% saponin 
17% resins 
17% resins 
10% resins 
0.26% saponin 
0.24% saponin 
Ecosorb 
Ecosorb 
No 
No 
No 
N o  
Venting 
Mount agar slide 
Mount agar slide 
Mount agar slide 
Attach signal 
Centrifugation 
No 
N o  
No 
No 
No 
No 
No 
Venting 
No 
Venting 
Venting 
N o  
No 
No 
BHI, brain-heart infusion broth; MB, Middlebrook PP, proteose peptone broth; SCD, soybean-casein mgest broth; SCE’, soycasein peptone 
broth; SPS, sodium polyanetholsulfonate; TSB, tryptic soy broth 
acceptable detection time standard is the incubation 
time required to reveal a positive blood culture, without 
considering the transport time. 
MANUAL SYSTEMS 
Conventional broth-based blood-culture methods are 
technically simple, but labor-intensive, since visual 
inspection is required. Each bottle should be examined 
daily for macroscopic signs of microbial growth, such as 
turbidity of the medium, hemolysis, gas production, or 
formation of colonies. A great variety of broth blood- 
culture media are commercially available (Table 4). 
Furthermore, laboratories can produce their own 
blood-culture vials, depending on their resources. 
Generally, blood-culture bottles contain 50-1 00 mL. of 
broth, which is supplemented with 0.025-0.05% 
sodium polyanetholsulfonate (SPS) . Of two bottles 
inoculated, one should be transiently vented, to create 
an aerobic atmosphere in the headspace of the bottle. 
Microscopic examination or terminal, blind subcultures 
of visually negative blood culturing is of little value [6]. 
Biphasic systems 
Biphasic blood-culture systems consist of a conven- 
tional broth medium which can flood, and thus inocu- 
late, a solid agar medium in a closed system, using 
different devices and techniques. 
Hernoline 
Back in 1947, a biphasic medium was described for 
convenient detection of Brucella spp. [31]. Similar to 
this biphasic Castaneda medium, the HCmoline aerobic 
vial (BioMCrieux, Lyon, France) is commercially 
available. A rectangular flask allows the agar to remain 
attached to the side of the bottle. About one-third of 
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Table 5 Time required after vial inoculation to detect positive blood cultures by technicians using diflerent blood-culture 
systems and media evaluated at the University Hospital Geneva 
Detection time (h) 
% positive 
No. of Average 24 h after vial 
System Medmm pathogens (tstandard deviation) Median inoculation Reference 
Septi-Chek Release 574 39 (220) 34 23 [I81 
Signal 515 39 (234) 27 45 ~171 
BacT/Alert Standard aerobic 519 27 (224) 20 68 ~ 7 1  
BacT/Alert Standard anaerobic 497 28 (-C22) 20 68 1171 
BACTEC Plus aerobic/F 524 31 (221) 24 50 [I81 
BACTEC Plus aerobic/F 894 28 (218) 22 52 1221 
BACTEC Plus anaerobic/F 527 37 (224) 30 39 [181 
BACTEC Lytic anaerobic/F 852 24 (213) 21 63 P I  
the agar surface remains in the 40 mL. of broth. The 
upper two-thirds of the agar is inoculated by simply 
turning the vial and flooding the surface. Colonies 
growing on the transparent agar are easily visible. 
In a smaller study that we conducted at the 
University Hospital Geneva, the performance of the 
HCmoline aerobic vial was similar to that of the Signal 
system [8] (Oxoid Ltd, Basingstoke, UK), but it was 
inferior to that of the Septi-Chek BHI medium 
(P=0.009) [S] or the Septi-Chek Release medium 
(P<O.OOOl) in another study [32], as illustrated in Table 
1. Mainly staphylococci and members of the Entero- 
bacteriaceae were recovered more often with the Septi- 
Chek media. In a further study, the HCmoline 
recovered less pathogens (P= 0.04) than the aerobic 
medium of the automated Vital system [33]. 
Septi-Chek 
This biphasic blood-culture system was developed by 
Hofhann-La Roche Diagnostics, Basel, Switzerland 
in the early 1980s. It was based on the dip slide 
bacteriologic urine-culture kit, widely used in physi- 
cians' ofices at that time. This kit consists of a 50-mL 
plastic container, and a paddle coated with agar media 
(CLED, MacConkey, etc.), attached to the screw cap 
[34]. By simply dipping this paddle into urine samples, 
and incubating the kit overnight at 35"C, semi- 
quantitative cultures are achieved. This urine-culture 
device has been slightly modified to fit onto 100-mL 
blood-culture bottles, the paddles being coated with 
appropriate media (chocolate, MacConkey agar); the 
result is the Septi-Chek aerobic blood-culture system. 
The bottles contain 70 mL. of broth medium. Gener- 
ally, the agar-coated slide device is attached in the 
laboratories to the bottles previously inoculated with 
blood. By simple inversion of this closed system, the 
agar surfaces of the paddle are flooded and inoculated 
with microorganisms present in the blood broth. The 
agar surfaces and the broth should be visually inspected 
for microbial growth twice daily for the first 2 days of 
incubation, and thereafter once a day up to the seventh 
day of incubation. For anaerobic blood cultures, con- 
ventional broth bottles that should not be vented are 
available for this system. 
This blood-culture system was first produced 
and marketed in Europe by Hofhann-La Roche 
Diagnostics, Basel, Switzerland with the name 'the 
BCB system', and in the USA by Roche Diagnostics, 
Nutley, NJ as the Septi-Chek system. As Septi-Chek, 
it is now marketed by Becton Dickinson Microbiology 
Systems, Cockeysville, MD, USA worldwide. 
Numerous evaluations have demonstrated the 
advantages of this system over conventional cultures 
[35-381 (Table l), other commercially available manual 
blood-culture systems [8,32,39-43] (Table l), and 
automated systems [18,44-471 (Table 2). We have 
performed several comparisons of this system at the 
University Hospital Geneva [8,9,18,42,43]. The results 
were very dependent on the basic medium used for this 
system. The best comparative results for the isolation of 
aerobic microorganisms could be achieved with the 
lytic Release medium [18,32,41-431. In particular, 
yeasts were readily isolated with this system [41,48,49]. 
A recently produced resin containing TSB medmm has 
been favorably evaluated [50]. 
The practical advantage of this technique is the 
closed system, which allows multiple subcultures, 
minimizing the risk of contamination. Furthermore, 
colonies on the slides of positive blood cultures can be 
used to perform standardized identification and sus- 
ceptibility procedures. In contrast, positive monophasic 
broth cultures require an overnight subculture on agar 
media before these standardized procedures can be 
performed [51]. The disadvantage of the Septi-Chek 
system is the necessary visual inspection of broth and 
agar slide of each individual bottle, which is labor- 
intensive and may explain the comparatively long 
detection time (Table 5). 
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Other biphasic systems 
Other biphasic systems have been described, such as the 
Vacutainer agar slant (Becton Dickinson Vacutainer 
Systems, Rutherford, NJ, USA) [52], the Opticult 
(Becton Dickinson Microbiology Systems, Cockeysville, 
MD, USA) [53], and a system by Gibco (Life 
Technologies, Inc., Inchinnan, UK) [54], but these 
have never achieved the popularity of the Septi-Chek 
system. 
Gas capture or broth displacement system 
Signal 
An original method of detecting microbial growth was 
described in 1986, the Signal system [55]. It is based on 
the principle that microbial metabolism produces posi- 
tive pressure in a sealed bottle, which can be visualized 
in a secondary plastic cylinder (Signal device) attached 
to the broth-containing bottles by a needle. The 
positive pressure in the bottle displaces blood broth into 
the upper cylinder through the needle. Hence, positive 
blood cultures can be easily seen by the presence of 
blood broth at a specific level in the Signal device. The 
manufacturer (Oxoid Ltd) claims that potential aerobic 
and anaerobic microorganisms causing sepsis can be 
isolated from one Signal bottle. 
The results obtained during the first evaluations of 
the Signal system were inferior (P<O.0001) to those of 
BACTEC 6B and 7D combined media [56]. Modi- 
fication of the bottle headspace atmosphere and 
agitation of the system during the first 24-48 h of 
incubation improved the performance of the system 
[53,57-591 (Table 2) .  In spite of these improvements, 
the single-bottle Signal system detected less pathogens 
than systems consisting of two media (aerobic and 
anaerobic) from the same volume of blood, i.e. about 
10mL per adult patient [17,57]. At the University 
Hospital Geneva, we found that the Signal system 
detected facultatively and strictly anaerobic bacteria 
well, which was complementary to the Septi-Chek 
aerobic system [8,9,42,43]. Similar findings were also 
reported elsewhere [39]. The easily visible and con- 
tinuous indication of positive Signal cultures allows 
relatively rapid detection of positive cultures for a 
manual system (Table 5). 
Lysis-centrifugation system 
Isolator 
A single-tube blood-culture system based on lysis, 
centrifugation and subsequent dlrect plating on appro- 
priate media was described in 1978 [60]. This system is 
now distributed as the Isolator system (Oxoid Ltd). The 
Isolator 10 tubes contain the following reagents in 
0.7 mL of aqueous solution: saponin (cell-lysing agent), 
propylene glycol (blocks the foaming tendency of 
saponin), and SPS (anticoagulant). At least 6 mL. of 
blood should be inoculated into these tubes, which 
must be processed as soon as possible, or at most 8 h 
after the inoculation of blood [61]. 
Tubes are centrifuged in the laboratory, preferably 
in a fixed-angle rotor (35') at 3000g for 30 min. The 
supernatant is discarded, and the pellet is inoculated on 
solid media. The Isostat device facilitates these manipu- 
lations and, furthermore, reduces the contamination 
rate. The Isolator 1.5, intended for pediatric patients, 
may be inoculated with a maximum of 1.5 mL of 
blood, and is processed without centrifugation. 
Many evaluations of the Isolator have been done, 
with variable results. Generally, the Isolator detected 
more pathogens than conventional blood cultures [62], 
the biphasic Septi-Chek TSB [46,63] or the ESP 
system [19,46,64,65]. The differences observed in two 
studies [41,66] comparing the Isolator to the Septi- 
Chek Release medium were due to the high number 
of Isolator cultures revealing Staphylococcus aureus, often 
with only one to two colonies on a single-agar medium 
in the study published by Kirkley et a1 [66]. The yield 
of pathogens with the Isolator was comparable to that 
with the BacT/Alert system using standard aerobic and 
anaerobic media [67], but inferior to those with the 
BACTEC 16A and 17A media 1681 and the BACTEC 
Plus aerobic/F medium [20,69]. The Isolator 1.5 for 
pediatric patients was comparable to the BacTIAlert 
Pedi-BacT medium [70], but the BACTEC Peds 
Plus/F medium revealed more pathogens than the 
Isolator 1.5 [28]. 
In general, some groups of organisms, such as yeasts, 
are well detected with the Isolator system. In particular, 
the Isolator represents an excellent method to reveal, 
for example, dimorphic fungi, mycobacteria, Legionella 
spp. and Bartonella spp. It remains the most convenient 
method for quantification of bacteremia or fungemia 
levels. However, quantitative blood cultures are of little 
value from the clinical point of view [71,72]. The 
availability of colonies on solid media 24 h after inocu- 
lation for most Isolator cultures is an advantage over 
other blood-culture media. Consequently, definitive 
identification or susceptibility results, obtained with a 
standardized inoculum, are available sooner. The 
saponin, however, may be toxic to some micro- 
organisms, and for this reason specimens should be 
processed within 8 h after inoculation of Isolator tubes 
[6 11. Organisms such as Streptococcus pneumoniae, Pseudo- 
monm aeruginosa, staphylococci or anaerobes have been 
reported to grow better in other systems [53]. The main 
disadvantage of the Isolator system is the labor- 
intensive initial processing before inoculation of culture 
media. These manipulations may be the reason for the 
relatively high contamination rate of Isolator cultures. 
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AUTOMATED SYSTEMS 
History 
Many techniques have been developed to reduce the 
technician manipulation time, to detect positive blood 
cultures more reliably, to reduce the contamination rate 
and to identify positive cultures more rapidly than 
manual systems. The positive clinical impact of rapid 
identification and susceptibility testing of blood-culture 
isolates has been demonstrated [73,74]. The detection 
of increased C02 concentrations due to microbial 
growth is widely applied with different techniques. The 
first instruments introduced in the early 1970s to detect 
CO2 concentrations in the headspace of vials were the 
radiometric BACTEC systems 225, 301, and 460 
(Johnston Laboratories, now Becton Dickinson 
Diagnostic Instrument Systems). The broth media 
contain substrates labeled with radioactive 14C, which 
is released as radioactive l4CO2 into the vial headspace 
during microbial metabolism. An ahquot of this head- 
space atmosphere of each individual bottle is drawn 
through a heat-sterilized needle. This sample is then 
analyzed for radioactivity, so that the instruments can 
establish growth indices. The air in the headspace of 
the bottle is replaced with an equal amount of non- 
radioactive gas. The major disadvantage of ths  system 
was the need for radioactive reagents. 
With the development of infrared spectro- 
photometric C02 detection, a new generation of 
blood-culture instruments was introduced in the 1980s 
by Becton Dickinson Diagnostic Instrument Systems, 
with the advantage of not requiring radioactive reagents 
(NR instruments). In addition, these instruments 
(BACTEC 660 and 730) reduced repeated handling 
operations. Bottles allowing an inoculation of up to 
10 mL of blood became available; previous vials were 
limited to only 5 d. In 1990, the more automated 
BACTEC 860 instrument was presented [75,76]. All 
three instruments share the disadvantage that every vial 
needs to be punctured to draw an air sample of the 
bottle headspace, which reduces the readmg rapidity. In 
addition, ths procedure increases the risk of cross- 
contamination from a positive to another previously 
negative vial and it requires a separate gas supply. At the 
time when these BACTEC instruments were the most 
widely used, a fine review by Wilson et a1 was published 
The BioArgos system (Sanofi Diagnostics Pasteur, 
Marnes-la-Coquette, France) also uses infrared spectro- 
photometric C02 detection, but it is read through the 
glass of the vials [78]. This non-invasive procedure 
eliminated the disadvantages related to the invasive 
technique mentioned above for the BACTEC 660,730 
or 860 instruments. Strictly speaking, this system is not 
1771. 
a continuous-monitoring blood-culture system, since 
several vials have to be moved regularly by a motorized 
arm to a common reading unit. Continuous- 
monitoring blood-culture systems use separate detect- 
ing units for each individual vial. However, the 
BioArgos shares many advantages of these systems. 
Unfortunately, to our knowledge, large-scale con- 
trolled clinical evaluations have not yet been reported 
with this system. 
Continuous-monitoring blood-culture systems 
A major advance in automated blood-culture systems 
was the introduction of continuous-monitoring blood- 
culture systems. These instruments share the virtues of: 
(1) incubators, agitation mechanisms, and detection 
units being integrated; (2) reduced handling time once 
the bottles have been loaded; (3) closed (non-invasive) 
detection systems, reducing cross-contamination, 
requiring no separate gas supply or sterilization of 
needles; and (4) continuous monitoring of bottles 
(every 10-25 min), so microbial growth is detected 
more rapidly. Recently, much data has been published 
on three of these innovative continuous-monitoring 
blood-culture systems, the BacTIAlert, the BACTEC 
9000 series, and the ESP (Extra Sensing Power). 
Interestingly, all three systems have been adapted and 
evaluated for mycobacterial culture capabilities 
[79-821. 
BacT/Alert 
The BacT/Alert (Organon Teknika, Turnhout, 
Belgium) was the first continuous-monitoring blood- 
culture system to receive FDA (Food and Drug 
Administration) approval, in 1990 [83,84]. It is based 
on the colorimetric detection of C02 concentrations 
by means of a sensor internally attached to the bottom 
of each blood-culture bottle. A membrane permeable 
only to C02 separates the sensor from the liquid 
contents of the vials. During microbial metabolism, the 
C02 concentration increases in the medium, which 
diffuses to the sensor, causing acidification and change 
in color of the sensor from green to yellow. Every 
10 min, light-emitting diodes light on the sensor and 
photodiodes measure the amount of reflected red light 
from the sensor, which is proportional to the color of 
the sensor, which in turn is proportional to the COz 
concentration. Each cell that receives a blood-culture 
bottle in the BacT/Alert instrument contains such a 
detection unit. The generated reflectance units are 
transferred to the microcomputer, which recognizes 
positive cultures by analyzing algorithms based on 
dfferent criteria, such as initial reading exceeding a 
predefined threshold, sustained linear increase or 
increased rate of COz production [77,83]. General 
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Table 6 Instrument characteristics of continuous-monitoring blood-culture systems according to Dunne et a16 and 
information supplied by the manufacturers 
Principle of Reading Agitation type Instruments Capacity Maximum 
System detection cycle (speed/min) available per unit no. of units Manufacturer 
RacTIAlert Colorimetric COZ 10 min Rocking (34) BacT/Alert 240 
BacT/Alert 120 
BACTEC 9000 Fluorescent COz 10 min Rocking (30) BACTEC 9240 
BACTEC 9120 
BACTEC 9050 
ESP Pressure change 12 min Rotary (160) ESP 384 
24 min” No” ESP 256 
ESP 128 
Vital Fluorescent COz 15 min Sinusoidal (150) Vital 400 
Vital 300 
Vital 200 
240 5 Organon Teknika, Turnhout, 
120 Belgium 
240 6 Becton Dicknson, Sparks, 
120 Md, USA 
50 
384 5 Accumed, East Grinstead, UK 
256 
128 
400 3 BioMkriew, Lyon, France 
300 
200 
’Anaerobic vials. 
characteristics of the BacT/Alert and of other 
continuous-monitoring blood-culture systems are 
listed in Table 6. 
BacT/Alert vials contain 40 mL. of medium, and 
accept up to 10 d of blood sample [7,85], with the 
exception of the pediatric Pedi-BacT (Table 4). An 
incubation period of 5 days has been determined to be 
acceptable for this system [86], due to the rapid 
detection of clinically relevant positive cultures. The 
performance of the system is very dependent on the 
medium used. In our laboratory, we compared the 
standard BacT/Alert aerobic and anaerobic media 
(inoculated with 5 d of blood each) with the manual 
Signal system (inoculated with 10 d) [17]. Signi- 
ficantly more pathogens could be detected with the 
two BacT/Alert media. Other studies found no 
statistically significant differences between the BacT/ 
Alert standard media and the Isolator [67] or the 
BACTEC NR6A and NR7A [87]. However, ESP 80A 
and SON [SS] and BACTEC resin media [24,30] 
recovered significantly more pathogens than the 
standard BacT/Alert media. The Pedi-BacT medium 
of the BacT/Alert detected significantly less pathogens 
than the BACTEC Peds Plus/F medium [89]. 
The ecosorb (absorbent charcoal and Fuller’s earth) 
supplemented BHI broth for the BacT/Alert FAN 
media significantly increased the yield over the standard 
media [15,16] or ESP S0A media [29,90], especially for 
patients receiving antimicrobial therapy when blood 
cultures were performed. These FAN media have been 
reported to be comparable to the BACTEC resin- 
containing media Plus aerobic/F and Plus anaerobic/F 
[21,23,91]. Wilson et al determined the antimicrobial 
neutralizing effect of the ecosorb supplement with a 
modified serum bactericidal test [16]. This study 
concluded that improved microbial yield with the FAN 
media was not due to inactivation of antimicrobial 
agents, and the reasons for this observation remain 
speculative. 
A disadvantage of the BacT/Alert system is that 
aerobic bottles need to be vented before loading into 
the instrument. This requirement may be a reason for 
higher contamination rates reported for these media 
[21]; in addition, it increases the risk of inadvertent 
needle sticks in the laboratory. 
BACTEC 9000 series 
The BACTEC 9120 and 9240 systems (Becton 
Dickinson Diagnostic Instrument Systems, Sparks, MD, 
USA) received FDA approval in 1992, the different 
capacity of 120 and 240 vials being the only difference 
between the two instruments [92]. More recently, the 
smaller 9050 system (holding up to SO vials) has been 
introduced [93]. These systems are similar to the 
BacT/Alert, detecting COz production with fluores- 
cent sensors attached to the bottom of each bottle 
instead of a colorimetric sensor used in the BacT/Alert 
system. All cells of the incubator blocks into which vials 
are loaded contain the fluorescence-monitoring device 
consisting of light-emitting diodes and the detecting 
photodiodes. The instrument determines the fluo- 
rescence of each bottle every 10 min and forwards the 
values to the computer. As COz concentrations increase 
during microbial growth, the fluorescence of the sensor 
increases, and the instrument recognizes positive cultures 
by computer algorithms or delta values. 
A great variety of F media is available for these 
instruments (Table 4). A first evaluation compared 
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standard F media with the NR media available for the 
BACTEC 660 N R  system [92]. An increased yield of 
staphylococci, members of the Enterobacteriaceae 
fanuly and pathogenic organisms overall was achieved, 
most probably due to the hlgher broth volume (40 mL 
versus 30 mL), lower SPS concentration (0.025% versus 
0.035%) and other slight differences in the basal 
medium formulations of the F versus the NR media 
Hollick et al. compared the standard anaerobic/F 
mehum to the Lytic anaerobic/F medium, and 
reported significantly better yield of Entero- 
bacteriaceae, streptococci and pathogenic organisms 
overall in the lytic medmm [94]. We reported signi- 
ficantly less instrument false-positive lytic vials than for 
vials containing non-lytic media and found it to be 
complementary to the resin-containing Plus aerobic/F 
medium [22]. Previously we have compared the resin- 
containing BACTEC Plus aerobic/F to another lytic 
medium, the Septi-Chek Release [18]. We observed a 
better yield of Streptococcus anginosus, members of the 
family Enterobacteriaceae, and pathogens overall for 
the Septi-Chek Release medmm [HI. Resin-con- 
taining Plus/F media have been reported to be superior 
to the Isolator [20,69] detecting more staphylococci, 
members of the Enterobacteriaceae family and l? 
aeruginosa [20]. These Plus/F media have been more 
sensitive than standard BacT/Alert [24,30] and Vital 
media [26], largely because of better detection of 
staphylococci. Furthermore, these resin media detected 
pathogenic organisms as well as earlier BACTEC resin 
media (NR26) produced for BACTEC 660 instru- 
ments [95]. Comparable results have also been 
published for BACTEC Plus/F media and ecosorb- 
supplemented BacT/Alert FAN media [21,23,91]. 
The BACTEC 9000 system detected positive 
cultures earlier than manual systems [18,69] or previous 
BACTEC N R  systems [95]. Other continuous-moni- 
toring blood-culture systems seem to detect positive 
cultures as early as the BACTEC 9000 instruments 
[21,23,24]. Evaluating the Plus aerobic/F and the Lytic 
anaerobic/F media, we appreciated the rapidity of the 
system in detecting positive cultures. Moreover, a 
comparatively low contamination rate of BACTEC F 
media has been generally observed. This advantage is 
probably due to the possibility of inoculating these 
BACTEC vials with vacutainer blood collection sets, 
which also reduces the risk of inadvertent needle sticks. 
Moreover, aerobic vials of this system do not require 
transient venting. 
~921. 
ESP (Extra Sensing Power) 
The ESP instrument (Accumed, East Grinstead, UK), 
at that time marketed by Difco Laboratories, Detroit, 
Mich, USA, was the third continuous-monitoring 
blood-culture system to receive FDA approval. It differs 
in many ways from the two systems described above 
(Table 6). Positive cultures are detected by manometric 
monitoring of gas production or consumption. Bottles 
are fitted with an adapter so that the instrument can 
monitor the pressure in the headspace of each aerobic 
bottle every 12 min and of each anaerobic bottle every 
24min. Only aerobic bottles are shaken (orbitally). 
Pressure changes are analyzed by the computer, and 
algorithms established by the producer allow the instru- 
ment to determine positive cultures. 
Clinical trials of the ESP system have shown a 
comparable performance to the Septi-Chek TSB 
medium [46], but the Isolator yielded more pathogens 
than the aerobic ESP 80A medium, which was mainly 
due to higher yield of staphylococci and yeasts 
[19,46,64,65]. ESP media detected significantly more 
anaerobes, Staphylococcus aureus and pathogens com- 
bined than the standard BacTIAlert media [88]. 
Concerning pediatric patients, no significant difference 
was reported between the ESP aerobic 80A medium 
and the Septi-Chek BHI PED [40] or the BacT/Alert 
aerobic FAN medium [29]. Laboratories at higher alti- 
tudes, or in regions where much atmospheric pressure 
change occurs, may be confronted with a compara- 
tively high number of undesirable false-positive signals 
[64,88]. 
Vital 
The Vital automated blood-culture system has been 
marketed since 1993 only in Europe by bioMtrieux, 
Marcy-l’Etoile, France. The broth medium is sup- 
plemented with a fluorescent liquid compound, 
emitting light in the visible spectrum. During microbial 
metabolism, this fluorescence disappears (quenched) 
through the production of C02, acidification or 
reduction of the medium. The instrument monitors 
the fluorescence of all bottles every 15min, and 
decreased fluorescence is analyzed by the computer of 
the system, to determine positive cultures according to 
three hfferent algorithms [96]. Vital bottles must be 
stored in the dark in order to preserve the fluorophores. 
Limited clinical evaluations of the Vital media have 
shown a comparable performance to the manual 
Htmoline medium [33], the Septi-Chek BHI-S 
biphasic and Schaedler media [97], and BACTEC 
standard media [98]. However, resin BACTEC media 
recovered significantly more clinically relevant micro- 
organisms than the Vital media [11,26]. 
Other automated systems 
The BioArgos system (Sanofi Diagnostics Pasteur, 
Marnes-la-Coquette, France) using infiared COz 
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detection through the glass of the vials has been 
mentioned above [78]. The Microscan blood-culture 
system (Microscan, West Sacramento, CA, USA) is 
based on COz detection with a fluorescent sensor 
attached to the bottom of each bottle, simdar to the 
principle applied for the BACTEC 9000 systems [77]. 
The OASIS (Oxoid Automated Septicemia Investiga- 
tion System) by Oxoid Ltd, Basingstoke, UK, is based 
on monitoring pressure in the headspace of culture 
bottles, comparable to the ESP system, but the 
detection system is different. A septum sealing each 
bottle moves according to the gas production or con- 
sumption during microbial metabolism, These changes 
are monitored by a high-resolution laser scanning across 
the septum. The septum height relative to a reference 
point is calculated [99]. The culture bottles of the 
Sentinel blood-culture system (Difco Laboratories Ltd, 
East Molesey, Surrey, UK) contain gold-plated and 
aluminum alloy electrodes. The system detects micro- 
bial growth by measuring relative changes in voltage 
produced in the media [loo]. The future of these four 
systems remains uncertain, and to our knowledge, 
large-scale clinical trials have not yet been communi- 
cated. 
PRACTICES 
Before the introduction of continuous-monitoring 
blood-culture systems, an international survey on blood 
culture practices was published in 1992 [loll .  Differ- 
ences between institutions situated in the USA (n=12), 
in Europe (n=46) and in Asia (n=9) have been 
observed. At the time of the study, most participants 
(n=36; 53.7%) used the BACTEC 460 or 660 instru- 
ment alone (n=21; 31.4%) or in combination with the 
Isolator for fungi (n=15; 22.4%). Manual broth or 
Septi-Chek systems were used by 29 (n=19 and 10 
respectively) participants located mainly in Europe 
(n=23). 
A survey conducted in 1996 by the United 
Kingdom National External Quality Assessment 
Scheme for Microbiology reported the use of blood- 
culture systems by 466 participating laboratories (31 1 
in the UK, 146 in other European countries, nine 
in other countries) [102]. Of these laboratories, 34% 
used BACTEC, 21% BacT/Alert, 17% Signal, 11% 
conventional, 5% Sentinel, 5% Septi-Chek, 5% Vital, 
2% Hkmoline and 0.5% Vacutainer blood-culture 
systems. 
In conclusion, blood-culture produced in-house 
may no longer be recommended, due to lack of sensi- 
tivity, quality control, and peer-reviewed evaluations. 
In contrast, commercially available blood-culture systems 
share the following advantages: quality control is per- 
formed by the manufacturer, large-scale production 
allows more standardized media and less lot-to-lot 
variations, and evaluations performed at different sites 
can be compared. For automated systems, expensive 
instruments have to be acquired, but labor time can be 
saved, and the time to detect a positive culture can be 
reduced compared to manual systems (Table 5). 
Therefore, clinical bacteriology laboratories not yet in 
possession of a continuous-monitoring blood-culture 
system should consider one of the well-studied systems 
described above. Depending on the institution served 
and the number of patients under antimicrobial therapy 
when blood cultures are performed, the use of media 
containing antimicrobial inactivating agents like resins 
or ecosorb may be advisable. We favor the routine use 
of an anaerobic medium for the reliable recovery of not 
only strictly anaerobic bacteria, but also of facultatively 
anaerobic bacteria such as streptococci and Escherichia 
coli [22]. The system can be selected in relation to the 
annual number of blood cultures performed and the 
instrument's capacities, indicated in Table 6. Blood- 
culture systems seem to have reached the limits of 
culture procedures. However, some blood-borne patho- 
genic organisms require other methods for detection. 
Considerable research is in progress applying nucleic 
acid amplification for many organisms that grow 
poorly, after a long incubation period, or not at all in 
cultures [103-1171. However, for the moment, only a 
few of these tests are routinely used for the diagnosis of 
bacteremia, fungemia or viremia [ 1 121. 
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